Advocate Group’s Amgen AMGN Stock Holding History

Advocate Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Sell	5,198 -280	-5%	-$95.8K	0.28%	78
2026 Q1	$1.93M	Sell	5,478 -19	-0.3%	-$6.77K	0.3%	74
2025 Q4	$1.8M	Sell	5,497 -37	-0.7%	-$11.7K	0.29%	76
2025 Q3	$1.56M	Sell	5,534 -253	-4%	-$73.4K	0.26%	76
2025 Q2	$1.62M	Sell	5,787 -371	-6%	-$105K	0.29%	73
2025 Q1	$1.92M	Sell	6,158 -17	-0.3%	-$5.02K	0.35%	69
2024 Q4	$1.61M	Sell	6,175 -38	-0.6%	-$11.3K	0.3%	72
2024 Q3	$2M	Sell	6,213 -42	-0.7%	-$13.7K	0.36%	70
2024 Q2	$1.95M	Sell	6,255 -268	-4%	-$78.7K	0.39%	69
2024 Q1	$1.85M	Sell	6,523 -240	-4%	-$70.2K	0.37%	71
2023 Q4	$1.95M	Sell	6,763 -797	-11%	-$217K	0.42%	73
2023 Q3	$2.03M	Sell	7,560 -813	-10%	-$203K	0.47%	66
2023 Q2	$1.86M	Sell	8,373 -1,349	-14%	-$313K	0.41%	67
2023 Q1	$2.35M	Sell	9,722 -1,775	-15%	-$436K	0.51%	65
2022 Q4	$3.02M	Sell	11,497 -819	-7%	-$220K	0.65%	58
2022 Q3	$2.78M	Sell	12,316 -480	-4%	-$116K	0.69%	52
2022 Q2	$3.11M	Buy	+12,796	New	+$3.14M	0.72%	51

Other funds holding AMGN

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Advocate Group's AMGN Position: Q2 2026 in Review

Advocate Group reduced its Amgen (AMGN) stake by 5.1% in Q2 2026, selling an estimated $95.8K and leaving 5,198 shares worth $1.88M. The position accounts for 0.28% of the portfolio, ranked #78.

Advocate Group first reported a position in AMGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.11M in Q2 2022. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Advocate Group held 5,198 shares of Amgen worth $1.88M as of Q2 2026.
Advocate Group sold 280 Amgen shares in Q2 2026, an estimated $95.8K.
Amgen made up 0.28% of Advocate Group's portfolio in Q2 2026, its #78 holding.
Advocate Group first reported a position in Amgen in Q2 2022 and has held it in 17 quarters since.
Advocate Group's Amgen position peaked at $3.11M in Q2 2022.
1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advocate Group's 13F filing for Q2 2026, filed 17 Jul 2026.